Boston Partners
- SEC CIK
- 0001386060
- Latest filing
- Aug 4, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,819
- Value
- $5.43M
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,819 | $5.43M | <0.1% | +3,306+44.0% | Added | Holders |
| Q1 2026 | 7,513 | $3.69M | <0.1% | +6,993+1,344.8% | Added | Holders |
| Q4 2025 | 520 | $301.3K | <0.1% | +520 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −436−100.0% | Sold out | Holders |
| Q4 2024 | 436 | $226.8K | <0.1% | −33−7.0% | Reduced | Holders |
| Q3 2024 | 469 | $290.1K | <0.1% | −3−0.6% | Reduced | Holders |
| Q2 2024 | 472 | $261.0K | <0.1% | −334−41.4% | Reduced | Holders |
| Q1 2024 | 806 | $468.5K | <0.1% | −70−8.0% | Reduced | Holders |
| Q4 2023 | 876 | $465.0K | <0.1% | −948−52.0% | Reduced | Holders |
| Q3 2023 | 1,824 | $923.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,824 | $951.7K | <0.1% | −853−31.9% | Reduced | Holders |
| Q1 2023 | 2,677 | $1.54M | <0.1% | −6,353−70.4% | Reduced | Holders |
| Q4 2022 | 9,030 | $4.97M | <0.1% | −2,447−21.3% | Reduced | Holders |
| Q3 2022 | 11,477 | $5.82M | <0.1% | −4,254−27.0% | Reduced | Holders |
| Q2 2022 | 15,731 | $8.55M | <0.1% | +2,653+20.3% | Added | Holders |
| Q1 2022 | 13,078 | $7.72M | <0.1% | +2,669+25.6% | Added | Holders |
| Q4 2021 | 10,409 | $6.95M | <0.1% | −2,500−19.4% | Reduced | Holders |
| Q3 2021 | 12,909 | $7.38M | <0.1% | −5,782−30.9% | Reduced | Holders |
| Q2 2021 | 18,691 | $9.43M | <0.1% | +18,691 | New | Holders |